Newborn Screening Program Practices in the United States: Notification, Research, and Consent
Authors:
- 1 February 2002
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 109 (2) , 269-273
Abstract
Objective. To define current practice among US newborn screening programs for notification of results, research, and consenting procedures. Methods. A telephone survey of all US newborn screening program supervisors. Results. All 51 programs participated. All states reported abnormal results to the infant’s physician, and some also reported to the hospital and parents. Cases with abnormal results were tracked to different endpoints but usually (92.1%) at least until a follow-up appointment was made. A total of 66.6% of programs can communicate with programs in other states; 9.8% enable families to suppress reporting of results to the infant’s physician. No state has a mechanism for parents to prevent results from entering the medical record. Parents or physicians who request results are often authenticated by providing their name (52.9%). Many programs (45.1%) report only to physicians and require just their name (43.5%), an identification number (17.4%), a letter (26.1%), or a parent’s signature (26.1%). A total of 70.6% retain residual blood samples; of these, only 8.3% store them completely devoid of patient identifiers. A total of 49.0% of programs aggregate data for research. In 16.0% of these, the data are publicly available. In 24.0%, researchers obtain approval at their own institution; in 24.0%, researchers obtain approval through the state laboratory Institutional Review Board. In 74.5% of programs, parents are notified but not asked for consent before collection of the sample; 19.6% neither notify parents nor obtain consent before screening. Conclusions. There is wide variation in practice among the US newborn screening programs. Because the programs collectively manage a comprehensive nationwide genomic databank, careful consideration of how information technology and high-throughput genomic analysis are used will be essential to allow progress in clinical care, public health, and research while protecting individual privacy.Keywords
This publication has 10 references indexed in Scilit:
- Public standards and patients' control: how to keep electronic medical records accessible but private Commentary: Open approaches to electronic patient records Commentary: A patient's viewpointBMJ, 2001
- US Newborn Screening System Guidelines II: Follow-up of Children, Diagnosis, Management, and Evaluation Statement of the Council of Regional Networks for Genetic Services (CORN)The Journal of Pediatrics, 2000
- Neonatal screening: ethical aspectsActa Paediatrica, 1999
- Privacy and Medical-Records ResearchNew England Journal of Medicine, 1998
- Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States.American Journal of Public Health, 1997
- Weaving Technology and Policy Together to Maintain ConfidentialityJournal of Law, Medicine & Ethics, 1997
- Guidelines for the Retention, Storage, and Use of Residual Dried Blood Spot Samples after Newborn Screening Analysis: Statement of the Council of Regional Networks for Genetic ServicesBiochemical and Molecular Medicine, 1996
- Informed Consent for Genetic Research on Stored Tissue SamplesJAMA, 1995
- Informed consent for genetic research on stored tissue samples1995
- Postrelational database implementation for newborn screening and trackingJournal of Medical Systems, 1988